Terry Porter

SVP Business Development at Seal Rock Therapeutics - Seattle, WA, US

Terry Porter's Colleagues at Seal Rock Therapeutics
David Brown

Director Of Chemistry

Contact David Brown

Kathleen Elias

Co-founder; VP of Research and Translational Medicine

Contact Kathleen Elias

Terry Porter's Contact Details
HQ
786-453-0593
Location
Chicago,Illinois,United States
Company
Seal Rock Therapeutics
Terry Porter's Company Details
Seal Rock Therapeutics logo, Seal Rock Therapeutics contact details

Seal Rock Therapeutics

Seattle, WA, US • 5 - 9 Employees
BioTech/Drugs

Seal Rock Therapeutics, Inc. is discovering and developing small molecule inhibitors of ASK1 (apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological and neurodegenerative indications.

Inflammation Fibrosis NASH Heart Failure HFpEF ASK1
Details about Seal Rock Therapeutics
Frequently Asked Questions about Terry Porter
Terry Porter currently works for Seal Rock Therapeutics.
Terry Porter's role at Seal Rock Therapeutics is SVP Business Development.
Terry Porter's email address is ***@sealrocktx.com. To view Terry Porter's full email address, please signup to ConnectPlex.
Terry Porter works in the Research industry.
Terry Porter's colleagues at Seal Rock Therapeutics are Neil McDonnell, David Brown, Kathleen Elias and others.
Terry Porter's phone number is 786-453-0593
See more information about Terry Porter